European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo, porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2025 - 16:50

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo, porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo+MH RTU, porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2025 - 16:48

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo+MH RTU, porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2025 - 16:46

Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2025 - 16:25

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness